UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study

PLoS medicine, 2022-09, Vol.19 (9), p.e1004097-e1004097

2022

Volltextzugriff (PDF)

Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children

PloS one, 2019-05, Vol.14 (5), p.e0216868-e0216868

2019

Volltextzugriff (PDF)

Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations

Virology journal, 2021-04, Vol.18 (1), p.77-77, Article 77

2021

Volltextzugriff (PDF)

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

BMC infectious diseases, 2017-07, Vol.17 (1), p.496-496, Article 496

2017

Volltextzugriff (PDF)

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes

BMJ open, 2021-10, Vol.11 (10), p.e050116-e050116

2021

Volltextzugriff (PDF)

Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015

Viruses, 2021-07, Vol.13 (8), p.1423

2021

Volltextzugriff (PDF)

Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

PloS one, 2015-05, Vol.10 (5), p.e0126647

2015

Volltextzugriff (PDF)

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

The New England journal of medicine, 2021-12, Vol.385 (27), p.2531-2543

2021

Volltextzugriff (PDF)

Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay

Analytica chimica acta, 2019-09, Vol.1071, p.86-97

2019

Volltextzugriff (PDF)

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

PloS one, 2015-08, Vol.10 (8), p.e0137368-e0137368

2015

Volltextzugriff (PDF)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV

Clinical pharmacokinetics, 2020-10, Vol.59 (10), p.1185-1194

2020

Volltextzugriff (PDF)

Optimising Paediatric HIV Treatment: Recent Developments and Future Directions

Paediatric drugs, 2024-11, Vol.26 (6), p.631-648

2024

Volltextzugriff (PDF)

Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling

Clinical pharmacokinetics, 2020-11, Vol.59 (11), p.1433-1450

2020

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir

Clinical pharmacokinetics, 2021-06, Vol.60 (6), p.795-809

2021

Volltextzugriff (PDF)

Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention

Current HIV/AIDS reports, 2020-10, Vol.17 (5), p.487-498

2020

Volltextzugriff (PDF)

Youth‐friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a randomized control trial

Journal of the International AIDS Society, 2020-09, Vol.23 (S5), p.e25564-n/a

2020

Volltextzugriff (PDF)

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women

Clinical pharmacokinetics, 2018-11, Vol.57 (11), p.1421-1433

2018

Volltextzugriff (PDF)

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy

Clinical infectious diseases, 2015-07, Vol.61 (1), p.95-101

2015

Volltextzugriff (PDF)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment

Clinical infectious diseases, 2015-08, Vol.61 (4), p.633-639

2015

Volltextzugriff (PDF)

Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: An update

Infection, genetics and evolution, 2007-03, Vol.7 (2), p.333-342

2007

Volltextzugriff (PDF)

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents

Antiviral therapy, 2018-01, Vol.23 (3), p.259-265

2018

Volltextzugriff (PDF)

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy

Journal of antimicrobial chemotherapy, 2015-01, Vol.70 (1), p.217-224

2015

Volltextzugriff (PDF)

Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand

PLoS medicine, 2013-08, Vol.10 (8), p.e1001494-e1001494

2013

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Nur zeigenMit Volltextzugriff

ThemaHuman Immunodeficiency Virus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Hiv
(34)
Science & Technology
(31)
Humans
(27)
Life Sciences & Biomedicine
(26)
Antiretroviral Drugs
(23)
Female
(23)
Hiv Infections - Drug Therapy
(20)
Infectious Diseases
(18)
Aids
(17)
Acquired Immune Deficiency Syndrome
(15)
Drug Dosages
(15)
Male
(14)
Drug Therapy
(11)
Pregnancy
(11)
Adult
(10)
Antiretroviral Therapy
(10)
Clinical Trials
(10)
Pharmacokinetics
(10)
Pharmacology & Pharmacy
(10)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study

Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children

Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes

Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015

Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV

Efficacy and Safety of 1-Month Postpartum Zidovudine-Didanosine to Prevent HIV-Resistance Mutations after Intrapartum Single-Dose Nevirapine

Optimising Paediatric HIV Treatment: Recent Developments and Future Directions

Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling

Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir

Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention

Youth‐friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a randomized control trial

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment

Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: An update

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy

Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand

Aktive Filter

Suchergebnisse filtern